Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10464936 was granted and assigned to Xoc Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office. | 10464936 | November 5, 2019 | |||||||
Patent 10246458 was granted and assigned to Xoc Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office. | 10246458 | April 2, 2019 | |||||||
Patent 9657020 was granted and assigned to Xoc Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office. | 9657020 | May 23, 2017 | |||||||
Patent 9938277 was granted and assigned to Xoc Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office. | 9938277 | April 10, 2018 | |||||||
Patent 10301311 was granted and assigned to Xoc Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office. | 10301311 | May 28, 2019 | |||||||
10815235 | October 27, 2020 | ||||||||
Patent 9676776 was granted and assigned to Xoc Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office. | 9676776 | June 13, 2017 | |||||||
10703753 | July 7, 2020 | ||||||||
Patent 10308651 was granted and assigned to Xoc Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office. | 10308651 | June 4, 2019 | |||||||
Patent 9951070 was granted and assigned to Xoc Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office. | 9951070 | April 24, 2018 | |||||||
Patent 9815830 was granted and assigned to Xoc Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office. | 9815830 | November 14, 2017 | |||||||
Patent 9777016 was granted and assigned to Xoc Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office. | 9777016 | October 3, 2017 |